Association between soluble L-selectin and anti-JCV antibodies in natalizumab-treated relapsing-remitting MS patients

The results support the hypothesis of sL-selectin being connected to the anti-JCV antibody index values and possibly cellular L-selectin. Measurement of serum sL-selectin should be evaluated further as a potential biomarker for predicting the risk of developing PML.